Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$11.78
-3.9%
$13.36
$7.94
$19.11
$1.03B1.72869,828 shs925,234 shs
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
$68.32
-5.7%
$57.91
$18.08
$76.34
$712.75M0.67167,304 shs145,328 shs
908 Devices Inc. stock logo
MASS
908 Devices
$7.93
-10.1%
$7.24
$5.03
$9.34
$333.52M0.63264,483 shs242,172 shs
Transcat, Inc. stock logo
TRNS
Transcat
$87.72
-5.9%
$77.99
$50.23
$94.76
$870.93M0.71171,441 shs156,850 shs
The Rise of the Robots Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and industrial operations. This report explores the rise of “Physical AI,” highlights four key ways investors can gain exposure to the robotics revolution, and profiles seven leading companies positioned to benefit from the growing demand for intelligent automation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-0.65%-9.19%-10.84%-22.16%+49.51%
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
+4.71%-4.21%+28.82%+39.54%+273.11%
908 Devices Inc. stock logo
MASS
908 Devices
+1.85%-1.23%+24.40%+40.89%+27.83%
Transcat, Inc. stock logo
TRNS
Transcat
+3.37%+18.09%+23.78%+31.94%+16.68%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$11.78
-3.9%
$13.36
$7.94
$19.11
$1.03B1.72869,828 shs925,234 shs
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
$68.32
-5.7%
$57.91
$18.08
$76.34
$712.75M0.67167,304 shs145,328 shs
908 Devices Inc. stock logo
MASS
908 Devices
$7.93
-10.1%
$7.24
$5.03
$9.34
$333.52M0.63264,483 shs242,172 shs
Transcat, Inc. stock logo
TRNS
Transcat
$87.72
-5.9%
$77.99
$50.23
$94.76
$870.93M0.71171,441 shs156,850 shs
The Rise of the Robots Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and industrial operations. This report explores the rise of “Physical AI,” highlights four key ways investors can gain exposure to the robotics revolution, and profiles seven leading companies positioned to benefit from the growing demand for intelligent automation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-0.65%-9.19%-10.84%-22.16%+49.51%
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
+4.71%-4.21%+28.82%+39.54%+273.11%
908 Devices Inc. stock logo
MASS
908 Devices
+1.85%-1.23%+24.40%+40.89%+27.83%
Transcat, Inc. stock logo
TRNS
Transcat
+3.37%+18.09%+23.78%+31.94%+16.68%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
3.00
Buy$31.80169.95% Upside
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
3.00
Buy$43.67-36.09% Downside
908 Devices Inc. stock logo
MASS
908 Devices
2.00
Hold$12.0051.32% Upside
Transcat, Inc. stock logo
TRNS
Transcat
2.60
Moderate Buy$105.3320.08% Upside

Current Analyst Ratings Breakdown

Latest MASS, EYPT, TRNS, and FEIM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/28/2026
Transcat, Inc. stock logo
TRNS
Transcat
UpgradeSell (D)Sell (D+)
5/15/2026
Transcat, Inc. stock logo
TRNS
Transcat
UpgradeStrong SellHold
5/11/2026
908 Devices Inc. stock logo
MASS
908 Devices
DowngradeHold (C-)Sell (D-)
5/7/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Lower Price TargetOutperform$39.00 ➝ $37.00
5/5/2026
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
UpgradeHoldStrong-Buy
5/4/2026
Transcat, Inc. stock logo
TRNS
Transcat
Reiterated RatingSell (D)
4/21/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Reiterated RatingSell (D-)
4/13/2026
908 Devices Inc. stock logo
MASS
908 Devices
UpgradeSell (D+)Hold (C-)
4/6/2026
Transcat, Inc. stock logo
TRNS
Transcat
DowngradeHoldStrong Sell
3/18/2026
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
DowngradeBuy (B+)Hold (C+)
3/9/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Boost Price TargetBuy$31.00 ➝ $35.00
(Data available from 6/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$31.37M31.48N/AN/A$3.70 per share3.18
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
$69.81M9.63$2.52 per share27.10$5.75 per share11.88
908 Devices Inc. stock logo
MASS
908 Devices
$56.20M5.34N/AN/A$3.97 per share2.00
Transcat, Inc. stock logo
TRNS
Transcat
$331.88M2.47$4.39 per share19.97$32.21 per share2.72
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-$231.96M-$3.50N/AN/AN/A-3,566.63%-110.54%-90.15%8/5/2026 (Estimated)
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
$23.69M$0.7591.09N/AN/A10.78%12.69%7.84%7/9/2026 (Estimated)
908 Devices Inc. stock logo
MASS
908 Devices
$19.49M-$1.00N/AN/AN/A-62.40%-14.03%-10.40%8/4/2026 (Estimated)
Transcat, Inc. stock logo
TRNS
Transcat
$5.38M$0.58151.2441.77N/A1.62%5.84%3.78%8/3/2026 (Estimated)

Latest MASS, EYPT, TRNS, and FEIM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/26/2026Q4 2026
Transcat, Inc. stock logo
TRNS
Transcat
$0.51$0.56+$0.05$0.21$89.79 million$89.33 million
5/6/2026Q1 2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-$0.79-$0.99-$0.20-$0.99$0.35 million$0.70 million
3/11/2026Q3 2026
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
$0.3050$0.16-$0.1450$0.16$19.06 million$16.89 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
N/AN/AN/AN/AN/A
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
N/AN/AN/AN/AN/A
908 Devices Inc. stock logo
MASS
908 Devices
N/AN/AN/AN/AN/A
Transcat, Inc. stock logo
TRNS
Transcat
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
N/A
6.66
6.63
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
N/A
2.60
1.32
908 Devices Inc. stock logo
MASS
908 Devices
N/A
3.58
3.25
Transcat, Inc. stock logo
TRNS
Transcat
0.33
2.33
1.99

Institutional Ownership

CompanyInstitutional Ownership
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
99.41%
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
58.60%
908 Devices Inc. stock logo
MASS
908 Devices
88.06%
Transcat, Inc. stock logo
TRNS
Transcat
98.34%

Insider Ownership

CompanyInsider Ownership
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
5.13%
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
28.00%
908 Devices Inc. stock logo
MASS
908 Devices
28.20%
Transcat, Inc. stock logo
TRNS
Transcat
2.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
12083.84 million79.54 millionOptionable
Frequency Electronics, Inc. stock logo
FEIM
Frequency Electronics
2009.84 million7.09 millionNot Optionable
908 Devices Inc. stock logo
MASS
908 Devices
6037.81 million27.15 millionOptionable
Transcat, Inc. stock logo
TRNS
Transcat
1,4139.34 million9.08 millionOptionable

Recent News About These Companies

Analysts Set Expectations for Transcat Q1 Earnings
Transcat Q4 Earnings Call Highlights
Transcat Names Jaime Irick as CEO
Transcat, Inc. (TRNS) Q3 2026 Earnings Call Transcript

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Eyepoint Pharmaceuticals stock logo

Eyepoint Pharmaceuticals NASDAQ:EYPT

$11.78 -0.48 (-3.92%)
Closing price 04:00 PM Eastern
Extended Trading
$11.96 +0.19 (+1.57%)
As of 07:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

EyePoint Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is EYP-1901, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 2 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E to potentially improve outcomes in serious retinal diseases. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.

Frequency Electronics stock logo

Frequency Electronics NASDAQ:FEIM

$68.32 -4.10 (-5.66%)
Closing price 04:00 PM Eastern
Extended Trading
$67.00 -1.32 (-1.93%)
As of 07:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Frequency Electronics, Inc., together with its subsidiaries, engages in designing, development, and manufacturing of precision time and frequency control products and components for microwave integrated circuit applications. It operates through two segments, FEI-NY and FEI-Zyfer. The FEI-NY segment offers precision time and frequency control products for communication satellites, terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military; and provides design and technical support for satellite business. FEI-Zyfer segment offers global positioning system technologies to systems and subsystems for secure communications, both government and commercial, and other locator applications; and engages in sale and support of wireline telecommunications products, including US5G. It markets its products directly and through independent sales representative organizations located in the United States, Europe, and Asia. Frequency Electronics, Inc. was founded in 1961 and is headquartered in Mitchel Field, New York.

908 Devices stock logo

908 Devices NASDAQ:MASS

$7.93 -0.89 (-10.09%)
Closing price 04:00 PM Eastern
Extended Trading
$7.92 0.00 (-0.06%)
As of 05:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Transcat stock logo

Transcat NASDAQ:TRNS

$87.72 -5.52 (-5.92%)
Closing price 04:00 PM Eastern
Extended Trading
$85.87 -1.85 (-2.11%)
As of 05:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, energy and utilities, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.